PDCD4 and plasma cell myeloma: In the process of CAM-DR, the adhesion of myeloma cells to fibronectin (FN) via its surface integrinβ1 induces the expression of miR-182, which suppresses the expression of human programmed cell death 4 (PDCD4) and triggers downstream drug-resistance mechanisms.